Evidence map›Paper›PMID 34123952›Full record

ArticleEuropean journal of case reports in internal medicine2021

Arterial Dissection in Antiphospholipid Syndrome Patients: Two Case Reports and a Literature Review.

Kadhim Al-Banaa, Alfarooq Alshaikhli, Asal Al-Hareeri, Mohammed Abdelhalim, Alsadiq Al-Hillan, Tejas Joshi

Open access · goldAbstract read
In one paragraph

Article in European journal of case reports in internal medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Kadhim Al-BanaaDepartment of Haemostasis and Thrombosis, University of California San Diego Health, San Diego, CA, USA.
Alfarooq AlshaikhliDepartment of Medicine, University of Texas/Rio Grande Valley, Edinburg, TX, USA.
Asal Al-HareeriDepartment of Surgery, Harborview Medical Center, Seattle, WA, USA.
Mohammed AbdelhalimDepartment of Medicine, Beaumont Hospital, Dearborn, MI, USA.
Alsadiq Al-HillanDepartment of Gastroenterology, Beaumont Hospital, Royal Oak, MI, USA.
Tejas JoshiDepartment Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas, USA.
Beaumont Hospital, Royal Oak · USBaylor College of Medicine · USHarborview Medical Center · USThe University of Texas Rio Grande Valley · USUniversity of California, San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antiphospholipid syndrome (APS) is a multisystemic autoimmune disease which presents with thromboembolic disease, pregnancy complications and the presence of antiphospholipid antibodies. There are some reports of arterial dissections in different sites of the body associated with APS. We describe two patients with APS who developed ischaemic stroke as a result of vertebral artery dissection in the absence of acquired and genetic risk factors for arterial dissection. We also conducted a systematic review of the literature for cases of arterial dissection associated with APS. We suspect that APS may be a potential cause of vasculopathy and arterial dissection. Further research is needed to explore this possible association. LEARNING POINTS: Antiphospholipid syndrome (APS) is a major risk factor for stroke in young patients.APS may be associated with vasculopathy and arterial dissection.Patients should meet both clinical and laboratory criteria for a diagnosis of APS.

Indexed as

Antiphospholipid antibody syndromeAPSarterial dissectionstrokevasculopathy

Identifiers

PMID34123952
PMCPMC8191364
OpenAlexW3165300481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.